NMANX vs. NHS
Compare and contrast key facts about Neuberger Berman Mid Cap Growth Fund (NMANX) and Neuberger Berman High Yield Strategies Fund (NHS).
NMANX is managed by Neuberger Berman. It was launched on Mar 1, 1979. NHS is an actively managed fund by Neuberger Berman. It was launched on Jul 28, 2003.
Performance
NMANX vs. NHS - Performance Comparison
Loading graphics...
NMANX vs. NHS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
NMANX Neuberger Berman Mid Cap Growth Fund | -4.02% | 5.51% | 24.39% | 18.21% | -28.82% | 12.42% | 39.45% | 33.62% | -6.28% | 29.01% |
NHS Neuberger Berman High Yield Strategies Fund | -9.33% | 14.81% | 11.04% | 6.12% | -22.99% | 15.78% | 4.57% | 39.03% | -11.45% | 8.64% |
Returns By Period
In the year-to-date period, NMANX achieves a -4.02% return, which is significantly higher than NHS's -9.33% return. Over the past 10 years, NMANX has outperformed NHS with an annualized return of 11.19%, while NHS has yielded a comparatively lower 6.21% annualized return.
NMANX
- 1D
- 1.15%
- 1M
- -4.22%
- YTD
- -4.02%
- 6M
- -11.88%
- 1Y
- 8.66%
- 3Y*
- 11.34%
- 5Y*
- 2.74%
- 10Y*
- 11.19%
NHS
- 1D
- 0.15%
- 1M
- -14.25%
- YTD
- -9.33%
- 6M
- -6.17%
- 1Y
- -1.82%
- 3Y*
- 5.43%
- 5Y*
- -0.73%
- 10Y*
- 6.21%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
NMANX vs. NHS - Expense Ratio Comparison
NMANX has a 0.83% expense ratio, which is lower than NHS's 4.14% expense ratio.
Return for Risk
NMANX vs. NHS — Risk / Return Rank
NMANX
NHS
NMANX vs. NHS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Neuberger Berman Mid Cap Growth Fund (NMANX) and Neuberger Berman High Yield Strategies Fund (NHS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| NMANX | NHS | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.43 | -0.11 | +0.55 |
Sortino ratioReturn per unit of downside risk | 0.76 | -0.05 | +0.81 |
Omega ratioGain probability vs. loss probability | 1.10 | 0.99 | +0.10 |
Calmar ratioReturn relative to maximum drawdown | 0.63 | -0.09 | +0.72 |
Martin ratioReturn relative to average drawdown | 1.95 | -0.40 | +2.34 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| NMANX | NHS | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.43 | -0.11 | +0.55 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.12 | -0.05 | +0.16 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.50 | 0.37 | +0.13 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.50 | 0.35 | +0.15 |
Correlation
The correlation between NMANX and NHS is 0.35, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
NMANX vs. NHS - Dividend Comparison
NMANX's dividend yield for the trailing twelve months is around 24.06%, more than NHS's 16.71% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NMANX Neuberger Berman Mid Cap Growth Fund | 24.06% | 23.10% | 9.85% | 3.19% | 4.87% | 16.30% | 9.58% | 5.43% | 11.70% | 8.94% | 5.00% | 9.00% |
NHS Neuberger Berman High Yield Strategies Fund | 16.71% | 14.60% | 14.50% | 13.94% | 12.75% | 8.74% | 9.29% | 7.99% | 8.37% | 7.59% | 8.23% | 9.81% |
Drawdowns
NMANX vs. NHS - Drawdown Comparison
The maximum NMANX drawdown since its inception was -72.14%, which is greater than NHS's maximum drawdown of -64.67%. Use the drawdown chart below to compare losses from any high point for NMANX and NHS.
Loading graphics...
Drawdown Indicators
| NMANX | NHS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -72.14% | -64.67% | -7.47% |
Max Drawdown (1Y)Largest decline over 1 year | -17.71% | -17.43% | -0.28% |
Max Drawdown (5Y)Largest decline over 5 years | -38.10% | -37.43% | -0.67% |
Max Drawdown (10Y)Largest decline over 10 years | -38.10% | -42.97% | +4.87% |
Current DrawdownCurrent decline from peak | -13.21% | -14.80% | +1.59% |
Average DrawdownAverage peak-to-trough decline | -17.45% | -8.82% | -8.63% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.71% | 4.11% | +1.60% |
Volatility
NMANX vs. NHS - Volatility Comparison
Neuberger Berman Mid Cap Growth Fund (NMANX) has a higher volatility of 8.86% compared to Neuberger Berman High Yield Strategies Fund (NHS) at 6.28%. This indicates that NMANX's price experiences larger fluctuations and is considered to be riskier than NHS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| NMANX | NHS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.86% | 6.28% | +2.58% |
Volatility (6M)Calculated over the trailing 6-month period | 16.46% | 10.99% | +5.47% |
Volatility (1Y)Calculated over the trailing 1-year period | 23.80% | 16.03% | +7.77% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 23.15% | 16.16% | +6.99% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.36% | 16.67% | +5.69% |